Congenital dyserythropoietic anaemias: Clinical features, haematological morphology and new biochemical data

Blood Reviews

Volumn 12, Issue 3, 1998, Pages 178-200

  Wickramasinghe, S N ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; OLIGOSACCHARIDE;

BIOCHEMISTRY; BLOOD TRANSFUSION; CELL STRUCTURE; CLINICAL FEATURE; ERYTHROCYTE MEMBRANE; HEMATOLOGY; HEREDITARY HEMOLYTIC ANEMIA; HUMAN; IRON OVERLOAD; PRIORITY JOURNAL; REVIEW; SWEDEN;

EID: 0031685438     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(98)90016-9     Document Type: Article

References (117)

1. Wickramasinghe SN. Dyserythropoiesis and congenital dyserythropoietic anaemias. Br J Haematol 1997; 98: 785-797.
2. Marks PW, Mitus AJ. Congenital dyserythropoietic anemias. Am J Hematol 1996; 51: 55-63.
3. Wickramasinghe SN, Lee MJ, Furukawa T, Eguchi M, Reid CDL. Composition of the intra-erythroblastic precipitates in thalassaemia and congenital dyserythropoietic anaemia (CDA): identification of a new type of CDA with intra-erythroblastic precipitates not reacting with monoclonal antibodies to α- and β-globin chains. Br J Haematol 1996; 93: 576-585.
4. Wickramasinghe SN, Hughes M. Globin chain precipitation, deranged iron metabolism and dyserythropoiesis in some thalassaemia syndromes. Haematologia 1984; 17: 35-55.
5. Heimpel H, Wendt F. Congenital dyserythropoietic anemia with karyorrhexis and multinuclearity of erythroblasts. Helv Med Acta 1968; 34: 103-115.
6. Thein SL, Hesketh C, Taylor P et al. Molecular basis for dominantly inherited inclusion body β-thalassaemia. Proc Natl Acad Sci USA 1990; 87: 3924-3928.
7. Wickramasinghe SN, Akinyanju OO, Hughes M. Dyserythropoiesis in homozygous haemoglobin C disease. Clin Lab Haematol 1982; 4: 373-381.
8. Wickramasinghe SN, Hughes M. Wasi P, Fucharoen S, Litwinczuk RAC. Ultrastructure and cell cycle distribution of erythropoietic cells in heterozygotes and homozygotes for haemoglobin E. Br J Haematol 1984; 57: 685-694.
9. Haworth C, Evans DIK, Mitra J, Wickramasinghe SN. Thiamine responsive anaemia: a study of two further cases. Br J Haematol 1982; 50: 549-561.
10. Frisch B, Lewis SM, Sherman D, White JM, Gordon-Smith EC. The ultrastructure of erythropoiesis in two haemoglobinopathies. Br J Haematol 1974; 28: 109-117.
11. Carter C, Darbyshire PJ, Wickramasinghe SN. Congenital dyserythropoietic anaemia variant presenting as hydrops foetalis. Br J Haematol 1989; 72: 289-290.
12. Williams G, Lorimer S, Merry CC, Greenberg CR, Bishop AJ. A variant congenital dyserythropoietic anaemia presenting as a fatal hydrops foetalis [comment]. Br J Haematol 1990; 76: 438-439.
13. Kristiansen JD, Rasmussen LN, Vetner M. Congenital dyserythropoietic anaemia (CDA) with intrauterine symptoms and early lethal outcome. Eur J Haematol 1990; 45: 113-114.
14. Cantu-Rajnoldi A, Zanella A, Conter U et al. A severe transfusion-dependent congenital dyserythropoietic anaemia presenting as hydrops fetalis. Br J Haematol 1997; 96: 530-533.
15. Wickramasinghe SN, Beatty C, Shiels S, Tomlinson DR, Harris JRW. Ultrastructure of the bone marrow in HIV infection: evidence of dyshaemopoiesis and stromal cell damage. Clin Lab Haematol 1992; 14: 213-229.
16. Abdalla S, Weatherall DJ, Wickramasinghe SN, Hughes M. The anaemia of P. falciparum malaria. Br J Haematol 1980; 46: 171-183.
17. Wickramasinghe SN, Looareesuwan S, Nagachinta B, White NJ. Dyserythropoiesis and ineffective erythropoiesis in Plasmodium vivax malaria. Br J Haematol 1989; 72: 91-99.
18. Wickramasinghe SN, Abdalla SH, Kasili EG. Ultrastructure of bone marrow in patients with visceral leishmaniasis. J Clin Pathol 1987; 40: 267-275.
19. Shalev H, Tamary H, Shaft D, Reznitsky P, Zaizov R. Neonatal manifestations of congenital dyserythropoietic anemia type I. J Pediatr 1997; 131: 95-97.
20. Heimpel H. Congenital dyserythropoietic anaemia type I. In: Lewis SM, Verwilghen RL, eds. Dyserythropoiesis. London: Academic Press, 1977: 50-70.
21. Tamary H, Shalev H, Luria D et al. Clinical features and studies of erythropoiesis in Israeli Bedouins with congenital dyserythropoietic anemia type I. Blood 1996; 87: 1763-1770.
22. Smithson WA, Perrault J. Use of subcutaneous deferoxamine in a child with hemochromatosis associated with congenital dyserythropoietic anemia, type I. Mayo Clin Proc 1982; 57: 322-325.
23. Wickramasinghe SN, Pippard MJ. Studies of erythroblast function in congenital dyserythropoietic anaemia, type I: evidence of impaired DNA, RNA, and protein synthesis and unbalanced globin chain synthesis in ultrastructurally abnormal cells. J Clin Pathol 1986; 39: 881-890.
24. Maeda K, Saeed M, Rebuck JW, Monto RW Type I dyserythropoietic anemia. A 30-year follow-up. Am J Clin Pathol 1980; 73: 433-438.
25. Hewitt PE, Win AA, Davies SC. CDA type I with persistent haemosiderinuria: absence of iron loading [letter]. Br J Haematol 1984; 56: 682-684.
26. Heimpel H, Wendt F, Klemm D, Schubothe H, Heilmeyer L. Kongenitale dyserythropoietische Anämie. Arch Klin Med 1968; 215: 174-194.
27. Clauvel JP, Cosson A, Breton-Gorius J et al. Dysérythropoièse congénitale. Nouv Rev Fr Hematol 1972; 12: 653-672.
28. Jean R, Dossa D, Navarro M, Rizkalla N, Lambert M-F, Wagner A. Anemie dyserythropoietique congenitale, type I. Arch Franc Péd 1975; 32: 337-348.
29. Holmberg L, Jansson L, Rausing A, Henriksson P. Type I congenital dyserythropoietic anaemia with myelopoietic abnormalities and hand malformations. Scand J Haematol 1978; 21: 72-79.
30. Hiraoka A, Kanayama Y, Yonezawa T, Kitani T, Tarui S, Hashimoto PH. Congenital dyserythropoietic anemia type I: a freeze-fracture and thin section electron microscopic study. Blut 1983; 46: 329-338.
31. Brichard B, Vermylen C, Scheiff JM, Michaux JL, Ninane J, Cornu G. Two cases of congenital dyserythropoietic anaemia type I associated with unusual skeletal abnormalities of the limbs. Br J Haematol 1994; 86: 201-202.
32. Le Merrer M, Girot R, Parent P, Cormier-Daire V, Maroteaux P. Acral dysostosis dyserythropoiesis syndrome. Eur J Pediatr 1995; 154: 384-388.
33. Alloisio N, Jaccoud P, Dorleac E et al. Alterations of globin chain synthesis and of red cell membrane proteins in congenital dyserythropoietic anemia I and II. Pediatr Res 1982; 16: 1016-1021.
34. Wickramasinghe SN, Hasan R, Menike D, Sandström H, Wahlin A. Serum thymidine kinase in congenital dyserythropoietic anaemia, type I and homozygous β-thalassaemia. Eur J Haematol 1997; 59: 333-334.
35. Heimpel H, Forteza-Vila J, Queisser W, Spiertz E. Electron and light microscopic study of the erythroblasts of patients with congenital dyserythropoietic anemia. Blood 1971; 37: 299-310.
36. Bethlenfalvay NC, Phaure TA, Phyliky RL, Bowman RP. Nuclear bridging of erythroblasts in acquired dyserythropoiesis: an early and transient preleukemic marker. Am J Hematol 1986; 21: 315-322.
37. Head DR, Kopecky K, Bennett JM et al. Pathogenetic implications of internuclear bridging in myelodysplastic syndrome. An Eastern Cooperative Oncology Group/Southwest Oncology Group Cooperative Study. Cancer 1989; 64: 2199-2202.
38. Lewis SM, Nelson DA, Pitcher CS. Clinical and ultrastructural aspects of congenital dyserythropoietic anaemia type I. Br J Haematol 1972; 23: 113-119.
39. Breton-Gorius J, Daniel MT, Clauvel JP, Dreyfus B. Anomalies ultrastructurales des érythroblastes et des érythrocytes dans six cas de dysérythropoièse congénitale. Nouv Rev Fr Hematol 1973; 13: 23-49.
40. Queisser W, Spiertz E, Jost E, Heimpel H. Proliferation disturbances of erythroblasts in congenital dyserythropoietic anemia type I and II, Acta Haematol 1971; 45: 65-76.
41. Lavabre-Bertrand T, Blanc P, Navarro R et al. Alpha-interferon therapy for congenital dyserythropoiesis type I. Br J Haematol 1995; 89: 929-932.
42. Virjee S, Hatton C. Congenital dyserythropoiesis type I and alpha-interferon therapy. Br J Haematol 1996; 94: 581-582.
43. Wickramasinghe SN. Congenital dyserythropoietic anaemia (CDA) type I; survey of cases in the UK and response to alpha interferon. Internat J Hematol 1996; 64: Suppl 1, S22.
44. Wickramasinghe SN. Response of CDA type I to alpha-interferon. Eur J Haematol 1997; 58: 121-123.
45. Wickramasinghe SN, Hasan R, Smythe J. Reduced interferon-alpha production by Epstein-Barr virus-transformed B-lymphoblastoid cell lines and lectin-stimulated lymphocytes in congenital dyserythropoietic anaemia, type I. Br J Haematol 1997; 98: 295-298.
46. Tamary H, Shalmon L, Shaley H et al. Localization of the gene for congenital dyserythropoietic anemia type I to chromosome 15q15.1-15.3. Blood 1996; 88: Suppl 1, 144a.
47. Crookston JH, Godwin TF, Wightman KJR et al. Congenital dyserythropoietic anaemia. Sydney: Abstracts from XIth Congress of the International Society of Haematology, 1966: 18.
48. Crookston JH, Crookston MC, Brunie KL et al. Hereditary erythroblastic multinuclearity associated with a positive acidified-serum test: a type of congenital dyserythropoietic anaemia. Br J Haematol 1969; 17: 11-26.
49. Verwilghen RL, Lewis SM, Dacie JV, Crookston JH, Crookston MC. HEMPAS: congenital dyserythropoietic anaemia (type II). QJM 1973; 166: 257-278.
50. Bird AR, Jacobs P, Moores P. Congenital dyserythropoietic anaemia (type II) presenting with haemosiderosis. Acta Haematol 1987; 78: 33-36.
51. Halpern Z, Rahmani R, Levo Y. Severe hemochromatosis: the predominant clinical manifestation of congenital dyserythropoietic anemia type 2. Acta Haematol 1985; 74: 178-180.
52. Tamura H, Matsumoto G, Itakura Y et al. A case of congenital dyserythropoietic anemia type II associated with hemochromatosis. Intern Med 1992; 31: 380-384.
53. Lugassy G, Michaeli J, Harats N, Libson E, Rachmilewitz EA. Paravertebral extramedullary hematopoiesis associated with improvement of anemia in congenital dyserythropoietic anemia type II. Am J Hematol 1986; 22: 295-300.
54. West NC, Meigh RE, Mackie M, Anderson MJ. Parvovirus infection associated with aplastic crisis in a patient with HEMPAS. J Clin Pathol 1986; 39: 1019-1020.
55. Barosi G, Cazzola M, Stefanelli M, Ascari E. Studies of ineffective erythropoiesis and peripheral haemolysis in congenital dyserythropoietic anaemia type II. Br J Haematol 1979; 43: 243-250.
56. Verwilghen RL, Tan P, de Wolf-Peeters C, Broeckaert-Van Orshoven A, Louwagie AC. Cell membrane anomaly impeding cell division. Experientia 1971 ; 27: 1467-1468.
57. Wong KY, Hug G, Lampkin BC. Congenital dyserythropoietic anemia type II: ultrastructural and radioautographic studies of blood and bone marrow. Blood 1972; 39: 23-30.
58. Alloisio N, Texier P, Denoroy L et al. The cisternae decorating the red blood cell membrane in congenital dyserythropoietic anemia (type II) originate from the endoplasmic reticulum. Blood 1996; 87: 4433-4439.
59. Wickramasinghe SN, Parry TE, Hughes M. Electron microscope autoradiographic studies of the erythroblasts of a case of congenital dyserythropoietic anaemia, type II. Scand J Haematol 1978; 20: 429-439.
60. Van Dorpe A, Broeckaert-Van Orshoven A, Desmet V, Verwilghen RL. Gaucher-like cells and congenital dyserythropoietic anaemia, type II (HEMPAS). Br J Haematol 1973; 25: 165-170.
61. Wickramasinghe SN. Human bone marrow. Oxford: Blackwell Scientific Publications, 1975: 349.
62. Cazzola M, Barosi G, Lambertenghi-Deliliers G, Paolini F, Riccardi A. Evidence for the existence of two populations of erythroid cells in a case of congenital dyserythropoietic anaemia type II. Haematologica 1982; 67: 508-516.
63. McBride JA, Wilson WEC, Baillie B. Congenital dyserythropoietic anemia type IV. Blood 1971; 38: 837.
64. Vermylen C, Scheiff JM, Rodhain J, Ninane J, Cornu G. A variant of the congenital dyserythropoietic anaemia type II with structural abnormalities in the granulocytic series. Eur J Pediatr 1986; 145: 232-235.
65. Borst-Eilers E, Moes M, Nyesse JC. A CDA family with a weak or variant HEMPAS antigen. London: Third Meeting of the European and African Division of the International Society of Haematology, 1975: Abstract 20.
66. Boogaerts MA, Verwilghen RL. Variants of congenital dyserythropoietic anaemia: an update. Haematologia 1982; 15: 211-219.
67. Lowenthal RM, Marsden KA, Dewar CL, Thompson GR. Congenital dyserythropoietic anaemia (CDA) with severe gout, rare Kell phenotype and erythrocyte, granulocyte and platelet membrane reduplication: a new variant of CDA type II. Br J Haematol 1980; 44: 211-220.
68. Baines AJ, Banga JP, Gratzer WB, Linch DC, Huehns ER. Red cell membrane protein anomalies in congenital dyserythropoietic anaemia, type II (HEMPAS). Br J Haematol 1982; 50: 563-574.
69. Scartezzini P, Forni GL, Baldi M, Izzo C, Sansone G. Decreased glycosylation of band 3 and band 4.5 glycoproteins of erythrocyte membrane in congenital dyserythropoietic anaemia type II. Br J Haematol 1982; 51: 569-576.
70. Mawby WJ, Tanner MJ, Anstee DJ, Clamp JR. Incomplete glycosylation of erythrocyte membrane proteins in congenital dyserythropoietic anaemia type II (CDA II). Br J Haematol 1983; 55: 357-368.
71. Bouhours JF, Bouhours D, Delaunay J. Abnormal fatty acid composition of erythrocyte glycosphingolipids in congenital dyserythropoietic anemia type II. J Lipid Res 1985; 26: 435-441.
72. Zdebska E, Anselstetter V, Pacuszka T et al. Glycolipids and glycopeptides of red cell membranes in congenital dyserythropoietic anaemia type II (CDA II). Br J Haematol 1987; 66: 385-391.
73. Fukuda MN, Klier G, Yu J, Scartezzini P. Anomalous clustering of underglycosylated band 3 in erythrocytes and their precursor cells in congenital dyserythropoietic anemia type II. Blood 1986; 68: 521-529.
74. Fukuda MN, Gaetani GF, Izzo P, Scartezzini P, Dell A. Incompletely processed N-glycans of serum glycoproteins in congenital dyserythropoietic anaemia, type II (HEMPAS). Br J Haematol 1992; 82: 745-752.
75. Fukuda MN, Dell A, Scartezzini P. Primary defect of congenital dyserythropoietic anemia type II. Failure in glycosylation of erythrocyte lactosaminoglycan proteins caused by lowered N-acetylglucosaminyltransferase II. J Biol Chem 1987; 262: 7195-7206.
76. Fukuda MN, Masri KA, Dell A, Thonar EJ, Klier G, Lowenthal RM. Defective glycosylation of erythrocyte membrane glycoconjugates in a variant of congenital dyserythropoietic anemia type II: association of low level of membrane-bound form of galactosyltransferase. Blood 1989; 73: 1331-1339.
77. Fukuda MN. HEMPAS disease: genetic defect of glycosylation. Glycobiology 1990; 1: 9-15.
78. Fukuda MN, Masri KA, Dell A, Luzzatto L, Moremen KW. Incomplete synthesis of N-glycans in congenital dyserythropoietic anemia type II caused by a defect in the gene encoding alpha-mannosidase II. Proc Natl Acad Sci USA 1990; 87: 7443-7447.
79. Iolascon A., D'Agostaro G, Perrotta S, Izzo P, Tavano R, Miraglia del Giudice E. Congenital dyserythropoietic anemia type II. Molecular basis and clinical aspects. Haematologica 1996; 81: 542-558.
80. Iolascon A, de Giudice EM, Perrotta S, Granatiero M, Zelante L, Gasparini P. Exclusion of three candidate genes as determinants of congenital dyserythropoietic anemia type II (CDA-II). Blood 1997; 90: 4197-4200.
81. Gasparini P, del Giudice EM, Delaunay J et al. Localization of the congenital dyserythropoietic anemia II locus to chromosome 20q11.2 by genomewide search. Am J Hum Genet 1997; 61: 1112-1116.
82. Bergström I, Jacobsson L. Hereditary benign erythroreticulosis. Blood 1962; 19: 296-303.
83. Lind L, Sandström H, Wahlin A et al. Localization of the gene for congenital dyserythropoietic anemia type III, CDAN3, to chromosome 15q21-q25. Hum Mol Genet 1995; 4: 109-112.
84. Sandström H, Wahlin A, Eriksson M, Holmgren G, Lind L, Sandgren O. Angioid streaks are part of a familial syndrome of dyserythropoietic anaemia (CDA III). Br J Haematol 1997; 98: 845-849.
85. Wolff JA, von Hofe FH. Familial erythroid multinuclearity. Blood 1951; 6: 1274-1283.
86. Accame EA, de Tezanos Pinto M. Diseritropoyesis congénita con polyploidía eritoblástica. A propósito de una variedad hallada en la Mesopotamia argentina. Sangre 1981; 26: 545-555.
87. Sandström H, Wahlin A, Eriksson M, Bergström I, Wickramasinghe, SN. Intravascular haemolysis and increased prevalence of myeloma and monoclonal gammopathy in congenital dyserythropoietic anaemia, type III. Eur J Haematol 1994; 52: 42-46.
88. Goudsmit R, Beckers D, de Bruijne JI et al. Congenital dyserythropoietic anaemia, type III. Br J Haematol 1972; 23: 97-105.
89. Wickramasinghe SN, Parry TE, Williams C, Bond AN, Hughes M, Crook S. A new case of congenital dyserythropoietic anaemia, type III: studies of the cell cycle distribution and ultrastructure of erythroblasts and of nucleic acid synthesis in marrow cells. J Clin Pathol 1982; 35: 1103-1109.
90. McCluggage WG, Hull D, Mayne E, Bharucha H, Wickramasinghe SN. Malignant lymphoma in congenital dyserythropoietic anaemia type III. J Clin Pathol 1996; 49: 599-602.
91. Byrnes RK, Dhru R, Brady AM, Galen WP, Hopper B. Congenital dyserythropoietic anemia in treated Hodgkin's disease. Hum Pathol 1980; 11: 485-486.
92. Sandström H, Wahlin A, Eriksson M, Bergström I. Serum thymidine kinase in congenital dyserythropoietic anaemia type III. Br J Haematol 1994; 87: 653-654.
93. Villegas A, Gonzalez L, Furio V et al. Congenital dyserythropoietic anemia type III with unbalanced globin chain synthesis. Eur J Haematol 1994; 52: 251-253.
94. Goudsmit R. Congenital dyserythropoietic anaemia, type III. In: Lewis SM, Verwilghen RL, eds. Dyserythropoiesis. London: Academic Press, 1977: 83-92.
95. Björksten B, Holmgren G, Roos G, Stenling R. Congenital dyserythropoietic anaemia type III: an electron microscopic study. Br J Haematol 1978; 38: 37-42.
96. Wickramasinghe SN, Goudsmit R. Some aspects of the biology of multinucleate and giant mononucleate erythroblasts in a patient with CDA, type III. Br J Haematol 1979; 41: 485-495.
97. Wickramasinghe SN, Wahlin A, Anstee D et al. Observations on two members of the Swedish family with congenital dyserythropoietic anaemia, type III. Eur J Haematol 1993 ; 50: 213-221.
98. Wickramasinghe SN, Goudsmit R. Precipitation of beta-globin chains within the erythropoietic cells of a patient with congenital dyserythropoietic anemia, type III [letter]. Br J Haematol 1987; 65: 250-251.
99. Wickramasinghe SN, Vora AJ, Will A et al. Transfusion-dependent congenital dyserythropoietic anaemia with non-specific dysplastic changes in erythroblasts. Eur J Haematol 1998; 60: 140-142.
100. Israels LG. The bilirubin shunt and shunt hyperbilirubinemia. In: Popper H, Schaffner F, eds. Progess in liver disease III. New York and London: Grune and Stratton Inc, 1970: 1-12.
101. Hamer JW, Fitzgerald PH. Disturbed bone marrow cell proliferation in primary shunt hyperbilirubinaemia. Blood 1973; 41: 539-547.
102. Frank DJ, Dusol M Jr, Schiff ER. Primary shunt hyperbilirubinemia with secondary iron overload: a case report. Gastroenterology 1979; 77: 754-757.
103. Ohisalo JJ, Vitala J, Lintula R, Ruutu T. A new congenital dyserythropoietic anaemia. Br J Haematol 1988; 68: 111-114.
104. Bird AR, Knottenbelt E, Jacobs P, Maigrot J. Primary shunt hyperbilirubinaemia: a variant of the congenital dyserythropoietic anaemias. Postgrad Med J 1991; 67: 396-398.
105. 12- and folate-independent megaloblastic change and absence of the defining features of congenital dyserythropoietic anaemia types I or III. Br J Haematol 1996; 95: 73-76.
106. Sechi LA, de Carli S, Catena C, Zingaro L, Bartoli E. Benign familial macrocytosis. Clin Lab Haematol 1996; 18: 41-43.
107. Ho PJ, Wickramasinghe SN, Rees DC, Lee MJ, Eden A, Thein SL. Erythroblastic inclusions in dominantly inherited β-thalassaemias. Blood 1997; 89: 322-328.
108. Wickramasinghe SN, Ilium N, Wimberley PD. Congenital dyserythropoietic anaemia with novel intra-erythroblastic and intra-erythrocytic inclusions. Br J Haematol 1991; 79: 322-330.
109. Parsons SF, Jones J, Anstee DJ et al. A novel form of congenital dyserythropoietic anaemia (CDA) associated with deficiency of erythroid CD44 and a unique blood group phenotype [In(a-b-), Co(a-b-)]. Blood 1994; 83: 860-868.
110. Agre P, Smith BL, Baumgarten R et al. Human red cell Aquaporin CHIP. II. Expression during normal fetal development and in a novel form of congenital dyserythropoietic anemia. J Clin Invest 1994; 94: 1050-1058.
111. Kenny MW, Ibbotson RM, Hand MJ, Tector MJ. Congenital dyserythropoietic anaemia with unusual cytoplasmic inclusions. J Clin Pathol 1978; 31: 1228-1233.
112. Pothier B, Morlé L, Alloisio N et al. Aberrant pattern of red cell membrane and cytosolic proteins in a case of congenital dyserythropoietic anaemia. Br J Haematol 1987; 66: 393-400.
113. Ariffin WA, Karnaneedi S, Choo KE, Normah J. Congenital dyserythropoietic anaemia: report of three cases. J Paediatr Child Health 1996; 32: 191-193.
114. Samson D, Halliday D, Chanarin I. Congenital dyserythropoietic anaemia: response to splenectomy and quantitation of ineffective erythropoiesis. J Clin Pathol 1977; 30: 184-190.
115. Choudhry VP, Saraya AK, Kasturi J, Rath PK. Congenital dyserythropoietic anaemias: splenectomy as a mode of therapy. Acta Haematol 1981; 66: 195-201.
116. Hirose M, Taguchi Y, Makimoto A, Yamada T, Okamoto T, Kuroda Y New variant of congenital dyserythropoietic anemia with trilineage myelodysplasia. Acta Haematol 1995; 94: 102-104.
117. Bird AR, Karabus CD, Hartley PS. Type IV congenital dyserythropoietic anemia with an unusual response to splenectomy. Am J Ped Hematol/Oncol 1985; 7: 196-199.